ACCESSION: MSBNK-SMB_Measured-HSA031P0135002
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.24, Processed 2025.02.24, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 10.000
COMMENT: MS2_M/Z_AVERAGED_THRES 15.000
COMMENT: DATASET_FILE_NUM 59
COMMENT: NUM_AVERAGED_SPEC 15
COMMENT: RAW_SPEC {'HC26-neg_865': {'bp': 1271.0, 'sum': 3645.0}, 'RA25-neg_844': {'bp': 884.0, 'sum': 2882.0}, 'HC14-neg_878': {'bp': 818.0, 'sum': 2472.0}, 'HC7-neg_809': {'bp': 811.0, 'sum': 2831.0}, 'RA20-neg_881': {'bp': 547.0, 'sum': 1551.0}, 'HC15-neg_838': {'bp': 543.0, 'sum': 1684.0}, 'RA2-neg_828': {'bp': 531.0, 'sum': 1572.0}, 'QC7-neg_818': {'bp': 495.0, 'sum': 1171.0}, 'HC23-neg_798': {'bp': 490.0, 'sum': 1193.0}, 'QC7-neg_831': {'bp': 486.0, 'sum': 1207.0}, 'RA11-neg_835': {'bp': 472.0, 'sum': 1480.0}, 'HC9-neg_799': {'bp': 350.0, 'sum': 1148.0}, 'QC4-neg_788': {'bp': 312.0, 'sum': 1158.0}, 'QC4-neg_780': {'bp': 254.0, 'sum': 610.0}, 'HC5-neg_532': {'bp': 203.0, 'sum': 407.0}}
COMMENT: RETENTION_TIME_STDEV 0.118
COMMENT: PRECURSOR_M/Z_RAW 135.031807
COMMENT: PRECURSOR_M/Z_STDEV 0.000404
COMMENT: PRECURSOR_IN_MS1 mz 135.031108; int 999.000; delta(ppm) -8.297903
COMMENT: PROPOSED_CHARGE_STATE -1; mz 136.033772; int 44.964; cor 0.950
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M+Na-2H; mz 157.013084; int 4.521; cor 0.697
COMMENT: PROPOSED_ION_FORM M+FA-H; M+Na-2H; mz 111.008156; int 4.132; cor 0.689
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.419; C5H4N4O; [M-H]1; delta(ppm) -0.418999
COMMENT: PROPOSED_MF SevenGoldenRules 9.416; C4H8O5; [M-H]1; delta(ppm) 9.416455
COMMENT: PROPOSED_MF MS-FINDER 4.886; C5H4N4O; [M-H]-; delta(ppm) -0.417291
COMMENT: PROPOSED_MF MS-FINDER 3.056; C4H8O5; [M-H]-; delta(ppm) 9.487282
COMMENT: PROPOSED_MF MS-FINDER 2.880; C5H12S2; [M-H]-; delta(ppm) 3.051520
COMMENT: PROPOSED_MF SIRIUS5_Sirius 19.136; C5H4N4O; [M-H]-; delta(ppm) -0.417291
COMMENT: PROPOSED_MF SIRIUS5_Sirius 4.629; C4H8O5; [M-H]-; delta(ppm) 9.487282
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.755; C5H12S2; [M-H]-; delta(ppm) 3.051520
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H4N4O; [M-H]-; delta(ppm) -0.417291
COMMENT: PROPOSED_MF SIRIUS6_Sirius 24.526; C5H4N4O; [M-H]-; delta(ppm) -0.417291
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.809; C2H5FN4O2; [M-H]-; delta(ppm) -8.879361
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.809; CH3FN4; [M+CH2O2-H]-; delta(ppm) 483758.623143
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.085; C7H6NO2; [M-H]-; delta(ppm) -10.360544
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.085; C6H4N; [M+CH2O2-H]-; delta(ppm) 483755.362205
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.252; C3H9N2O2P; [M-H]-; delta(ppm) -12.649615
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.252; C2H7N2P; [M+CH2O2-H]-; delta(ppm) 483750.322647
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.629; C4H8O5; [M-H]-; delta(ppm) 9.487282
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.629; C3H6O3; [M+CH2O2-H]-; delta(ppm) 2138877.510244
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.658; C4H9ClN2O; [M-H]-; delta(ppm) -150923.875916
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.434; CH7N5OP; [M-H]-; delta(ppm) -2.706408
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.245; C5H12S2; [M-H]-; delta(ppm) 3.051520
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.924; C5H5F3N; [M-H]-; delta(ppm) 7.748382
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.259; C2H7ClN5; [M-H]-; delta(ppm) -150916.707387
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H4N4O; [M-H]-; delta(ppm) -0.417291
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; CH3FN4; [M+CH2O2-H]-; delta(ppm) 483758.623143
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.600; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M-H]-; OC=1N=CC2=NCN=C2N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.272; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M-H]-; NC1=C(N=CN1C=O)C#N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.221; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M-H]-; OC1=NC=NC2=C1NC=N2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.200; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M-H]-; ON1N=NC=2C=CC=NC21
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.200; VHJRRKBEQDXLHP-UHFFFAOYSA-N; [M-H]-; C1=C2C(=NC=N1)N(C=N2)O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.729; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M-H]-; Hypoxanthine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.103; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M-H]-; Allopurinol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.863; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M-H]-; 2-hydroxypurine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.799; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M-H]-; 5-amino-1-formylimidazole-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.736; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M-H]-; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.730; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M-H]-; CNP0440561
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.692; VHJRRKBEQDXLHP-UHFFFAOYSA-N; [M-H]-; 9-hydroxypurine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.683; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M-H]-; 3H-pyrazolo[4,3-d]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.645; NYNNJBKGLLSTAZ-UHFFFAOYSA-N; [M-H]-; CNP0439982
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.592; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M-H]-; 1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.729; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M-H]-; 3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.689; JPIJQSOTBSSVTP-MZTXYVAJNA-N; [M-H]-; Erythronic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.971; IASCKZVQSNCRPV-UHFFFAOYSA-N; [M-H]-; 2,2,4-trihydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.911; FHEQBJDIKIFJTB-UHFFFAOYSA-N; [M-H]-; 3-hydroxy-3-(methylperoxy)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.890; DPLYGYOSWLFGGY-UHFFFAOYSA-N; [M-H]-; 1-Pentanesulfenothioic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.838; PUUCPZKSTXFGOC-UHFFFAOYSA-N; [M-H]-; Ethyl isopropyl disulfide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.838; SNGRPWPVGSSZGV-UHFFFAOYSA-N; [M-H]-; Ethyl propyl disulfide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.786; BBYNYNMPOUQKKS-UHFFFAOYSA-N; [M-H]-; 2,2-Bis(methylthio)propane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.786; QTWVOHZEDPQFTP-MLHKIVSYNA-N; [M-H]-; UNPD3575
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.734; KMTUBAIXCBHPIZ-UHFFFAOYSA-N; [M-H]-; pentane-1,5-dithiol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M-H]-; CNP0440561
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.979; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M-H]-; 1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.870; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M-H]-; 5-amino-1-formylimidazole-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.730; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M-H]-; 3H-pyrazolo[4,3-d]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.728; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M-H]-; Hypoxanthine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.728; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M-H]-; Allopurinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.728; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M-H]-; 2-hydroxypurine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.728; NYNNJBKGLLSTAZ-UHFFFAOYSA-N; [M-H]-; CNP0439982
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.710; VHJRRKBEQDXLHP-UHFFFAOYSA-N; [M-H]-; 9-hydroxypurine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.700; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M-H]-; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.661; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M-H]-; 3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JPIJQSOTBSSVTP-MZTXYVAJNA-N; [M-H]-; Erythronic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; IASCKZVQSNCRPV-UHFFFAOYSA-N; [M-H]-; 2,2,4-trihydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FHEQBJDIKIFJTB-UHFFFAOYSA-N; [M-H]-; 3-hydroxy-3-(methylperoxy)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.610; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M-H]-; 1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; JPIJQSOTBSSVTP-STHAYSLISA-N; [M-H]-; (2R,3S)-2,3,4-trihydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.140; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M-H]-; 1,7-dihydropurin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.494; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M-H]-; 3-hydroxytriazolo[4,5-b]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; QBKYWNHLILCGEI-UHFFFAOYSA-N; [M-H]-; 4-cyano-1H-imidazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; DHQDPICNDWFEBQ-UHFFFAOYSA-N; [M-H]-; 5H-pyrazolo[1,5-d][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.004; QICFIUZWDPJRQF-UHFFFAOYSA-N; [M-H]-; 1,6-dihydropyrazolo[3,4-d]pyridazin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M-H]-; 1,6-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; QMFPURRPZZSJPF-UHFFFAOYSA-N; [M-H]-; 3H-imidazo[2,1-f][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.868; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M-H]-; 3,7-dihydropurin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.851; GLVYFVYELPFNQC-UHFFFAOYSA-N; [M-H]-; 6H-pyrazolo[5,1-c][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.850; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M-H]-; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.823; GXBDCPYXMVITMR-UHFFFAOYSA-N; [M-H]-; 1H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.774; DSZCQHJBMSIMNX-UHFFFAOYSA-N; [M-H]-; 3,6-dihydroimidazo[4,5-d]pyridazin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.774; RDHMBEKEDDDWOF-UHFFFAOYSA-N; [M-H]-; 4H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.772; RBWFEMOYMLQPAV-UHFFFAOYSA-N; [M-H]-; 1,5-dihydropyrazolo[3,4-d]pyridazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.746; CLGWVBPVZYVPMR-UHFFFAOYSA-N; [M-H]-; 2H-[1,2,4]triazolo[4,3-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.710; JDPCCIANHKTFII-UHFFFAOYSA-N; [M-H]-; 6H-[1,2,4]triazolo[1,5-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.709; VNMKCHFGAZFWKI-UHFFFAOYSA-N; [M-H]-; 6H-[1,2,4]triazolo[4,3-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; GJDZQWVZICYPIT-UHFFFAOYSA-N; [M-H]-; [1,3]oxazolo[5,4-d]pyrimidin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.675; REINGZOTPYBONL-UHFFFAOYSA-N; [M-H]-; [1,2]oxazolo[5,4-d]pyrimidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.622; WKOSBXIJGCIJII-UHFFFAOYSA-N; [M-H]-; [1,2]oxazolo[4,5-b]pyrazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.185; LGSBQUSNSQFXGC-UHFFFAOYSA-N; [M-H]-; 2-hydroxy-2-(2-hydroxyethoxy)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.175; ZQBWCQHCMJERPW-UHFFFAOYSA-N; [M-H]-; 2-(1,2-dihydroxyethoxy)acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -54.825; FDGQSTZJBFJUBT; [M-H]-; Sarcine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -82.597; OFCNXPDARWKPPY; [M-H]-; Ailurial
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -89.502; CRIZPXKICGBNKG; [M-H]-; 2-Purinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -102.859; JFZSDNLQDTYVEE; [M-H]-; Zyloprim (TN)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -113.052; YPDSIEMYVQERLJ; [M-H]-; 7H-Purin-8-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -123.290; JDPCCIANHKTFII; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -133.652; NYNNJBKGLLSTAZ; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -137.465; GXBDCPYXMVITMR; [M-H]-; [1,2,4]Triazolo[1,5-a]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.115; DHQDPICNDWFEBQ; [M-H]-; AmbscX-046497
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.550; FPIRBHDGWMWJEP; [M-H]-; 1-Hydroxy-7-azabenzotriazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -187.230; CYYQSLSRZGVVHE; [M-H]-; Purine 3-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.321; QBKYWNHLILCGEI; [M-H]-; ACMC-20amkb
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.768; OGCXIHWGXUQTCQ; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.282; AXEBUIBRUVSSHM; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.330; FDGQSTZJBFJUBT; [M-H]-; Sarcine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -48.671; FDGQSTZJBFJUBT; [M-H]-; Sarkin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -60.027; OFCNXPDARWKPPY; [M-H]-; 2H-pyrazolo[3,4-d]pyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -77.468; CRIZPXKICGBNKG; [M-H]-; 7H-purin-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -83.560; JFZSDNLQDTYVEE; [M-H]-; 7-Hydroxypyrazolo[4,3-d]pyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -86.815; JDPCCIANHKTFII; [M-H]-; 6H-[1,2,4]Triazolo[1,5-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -92.381; ONMSHVSDDXZRPS; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -96.968; RBWFEMOYMLQPAV; [M-H]-; 1,5-Dihydropyrazolo[3,4-d]pyridazin-2-ium-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -101.486; NYNNJBKGLLSTAZ; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -102.187; QICFIUZWDPJRQF; [M-H]-; 1,6-Dihydropyrazolo[3,4-d]pyridazin-2-ium-7-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -114.693; RDHMBEKEDDDWOF; [M-H]-; 1,4-Dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-8-ium-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.159; FDGQSTZJBFJUBT; [M-H]-; Sarkin
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C5H3N4O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY -30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.5 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 10.00; MS2(ppm) 15.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 µm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min, 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.361
MS$FOCUSED_ION: PRECURSOR_M/Z 135.031178
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-014l-9000000000-9dc46ab2dc510ddc0758
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  65.0142421 924.2553 65.013905 11.1360 112.38 0.7170 15 f{C3H1N2}/-4.30ppm,p-C2H2N2O1
  66.0090265 351.0416 66.008687 8.4988 124.39 0.5583 13 f{C2N3}/-11.27ppm,p-C3H3N1O1
  92.0249184 999.0000 92.024531 8.1608 77.18 0.8158 15 f{C4H2N3}/-5.46ppm,p-C1H1N1O1
  135.0302676 175.4506 135.029846 16.2852 53.95 1.0000 13 f{C5H3N4O1}/-7.16ppm,p
PK$NUM_PEAK: 4
PK$PEAK: m/z int. rel.int.
  65.014242 924.26 924
  66.009026 351.04 351
  92.024918 999.00 999
  135.030268 175.45 175
//
